H. Res. 755 is a simple, nonbinding House resolution that expresses congressional support for the goals of “National Hydrocephalus Awareness Month” and “World Hydrocephalus Day” and calls for continued support of research to prevent, detect, and treat hydrocephalus.
The text collects a series of factual findings—prevalence, surgical burden, links to traumatic brain injury (TBI), and gaps in adult transition care—that frame why awareness and research proponents are seeking more attention.
For professionals, the resolution matters because it elevates hydrocephalus in congressional record and public awareness without creating obligations or appropriations. The measure signals potential political support for advocacy and research initiatives, and it compiles several statistics (prevalence, hospital costs, surgical volumes, and TBI links) that stakeholders may use to justify future legislative or funding proposals.
At a Glance
What It Does
The resolution records congressional findings about hydrocephalus, formally supports the goals of a designated awareness month and World Hydrocephalus Day, and states that the House will continue to support research to prevent, detect, and treat the condition. It does not authorize funding, change regulatory authority, or impose duties on federal agencies.
Who It Affects
Patients living with hydrocephalus, their caregivers, advocacy groups (notably the Hydrocephalus Association and the Pediatric Hydrocephalus Foundation), neurosurgeons and clinical researchers, and veteran health stakeholders are the primary audiences. The resolution may also influence institutions that track disease burden or seek federal research dollars.
Why It Matters
Symbolic congressional endorsements can raise profile, mobilize donors, and shape agency priorities, even when not legally binding. Policymakers, health systems, and researchers should view this as a visibility boost that could precede more concrete funding or policy proposals.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
H. Res. 755 opens with a set of findings—called “Whereas” clauses—that summarize the scope and consequences of hydrocephalus.
The drafters list national prevalence estimates, a global incidence rate, pediatric risk, the prevalence of normal pressure hydrocephalus among older adults (and high levels of underdiagnosis), annual hospital charges, and the connection between traumatic brain injury and subsequent hydrocephalus. The preamble also quantifies surgical burdens (shunt procedures and pediatric admissions) and highlights problems in the transition from pediatric to adult care.
Those findings are factual assertions in the resolution rather than regulatory findings that change law.
The operative text contains two short directives. First, the House formally expresses its support for the aims of “National Hydrocephalus Awareness Month” and “World Hydrocephalus Day,” echoing recognitions already established by advocacy organizations.
Second, the House states that it will continue to support research to prevent, detect, and treat hydrocephalus. Neither clause creates spending authority, directs agencies to change practice, nor establishes new reporting or monitoring requirements.Practically, this is a posture-setting document.
For clinicians and researchers, the resolution bundles key epidemiological and care-gap claims into the congressional record, which advocates can cite when seeking grants or programs. For federal health agencies and the Department of Veterans Affairs, the text signals congressional interest in hydrocephalus—useful context if future appropriations or programmatic changes are proposed—but it does not compel action.
For providers and health systems, the resolution highlights pressure points (device failure rates, emergency surgeries, transition-of-care gaps) but leaves solutions unspecified.
The Five Things You Need to Know
The resolution expressly supports the goals and ideas of “National Hydrocephalus Awareness Month” and “World Hydrocephalus Day.”, It directs the House to continue supporting research to prevent, detect, and treat hydrocephalus, though it authorizes no funding or new programs.
The bill states hydrocephalus affects approximately 1,000,000 people in the United States and cites a global incidence rate of 85 per 100,000 individuals.
Lawmakers note a link to traumatic brain injury: since 2000 more than 470,000 U.S. servicemembers sustained a TBI, and the resolution cites an estimated 14% risk of developing hydrocephalus after severe TBI.
The text records surgical and health-service burdens: over 36,000 shunt surgeries are performed annually (the text says one every 15 minutes) with more than 10,000 pediatric hospital admissions for shunt malfunctions each year.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Compiles prevalence, clinical burden, and care-gap findings
This section assembles the bill’s factual record: U.S. and global prevalence numbers, pediatric incidence, the estimated burden of normal pressure hydrocephalus among older adults (including a high underdiagnosis rate), the annual hospital cost figure, the connection between traumatic brain injury and hydrocephalus, and operational metrics on shunt surgeries and pediatric admissions. Practically, those findings serve as evidence intended to justify attention and future action; they do not create new regulatory standards or funding paths.
Formal endorsement of awareness observances
The House ‘‘supports the goals and ideas’’ of the named awareness month and day. This is a symbolic endorsement that can be cited by advocacy groups and used in outreach and awareness campaigns. It does not change the legal status of those observances (the text itself notes the month and day are recognized by nonprofit organizations) and imposes no duties on federal agencies or private entities.
Statement of continued support for research
The House states it will continue to support research to prevent, detect, and treat hydrocephalus. The wording signals congressional encouragement for ongoing scientific work but contains no appropriations language, no requirement for specific agencies to act, and no metrics or timelines for what ‘‘support’’ entails.
Nonbinding, informational posture
As a simple House resolution, H. Res. 755 is nonbinding and serves to put congressional sentiment on the record. The document references advocacy organizations and clinical statistics but includes no implementation text, no changes to federal law, and no compulsory directives—so its immediate operational impact is limited to political and rhetorical weight.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Patients with hydrocephalus and their families — Increased congressional visibility can improve public awareness, potentially reducing diagnostic delays and encouraging inclusion in clinical research recruitment and advocacy campaigns.
- Veterans and TBI survivors — The resolution highlights the TBI–hydrocephalus link, strengthening advocates’ cases for targeted screening and post-TBI monitoring within VA and DoD systems.
- Advocacy organizations (Hydrocephalus Association, Pediatric Hydrocephalus Foundation) — The measure validates their awareness calendar and provides a cited congressional finding set they can use for fundraising, awareness, and outreach.
- Clinical researchers and academic centers — The congressional record of support can be leveraged in grant narratives and institutional pitches to attract research funding and cross-institutional collaborations.
- Pediatric-to-adult care transition advocates — By calling out transition barriers, the resolution gives visibility to a frequently overlooked operational problem that could prompt pilot programs or policy proposals.
Who Bears the Cost
- Congressional staff and committees — Minimal administrative cost to draft, review, and record the resolution and to respond to constituent inquiries; no direct programmatic spending is authorized.
- Health systems and hospitals — If awareness efforts succeed, systems may see increased demand for specialized neurosurgical services and diagnostic evaluations without corresponding funding for capacity expansion.
- Veterans Health Administration and Department of Defense clinicians — The resolution may increase expectations for post-TBI screening or follow-up; responding to stakeholder pressure could require reallocating clinical resources even though the resolution imposes no mandate.
- Research sponsors and investigators — Heightened congressional focus can increase competition for limited research dollars and raise pressure to produce near-term outcomes, potentially shifting priorities within constrained portfolios.
- Pediatric and adult neurosurgeons — Spotlight on transition-of-care gaps may lead to advocacy for expanded adult-focused neurosurgical intake, creating demand for clinical time and training that institutions must absorb.
Key Issues
The Core Tension
The core tension is symbolic elevation versus concrete action: the resolution raises public and legislative attention to hydrocephalus and legitimizes advocacy claims, but because it lacks appropriations, mandates, or implementation details, it risks creating political momentum without providing the means—funding, regulatory change, or program structure—to address the clinical and care-delivery gaps it documents.
This resolution is primarily symbolic: it compiles a set of clinical and epidemiological claims and places congressional support for awareness and research on the record without creating funding authority or regulatory obligations. That creates a gap between expectation and mechanism—advocates gain a public-policy argument, but federal agencies and health systems receive no new resources or directives.
The bill’s factual findings are useful for advocacy but are not subject to the evidentiary or programmatic safeguards that accompany statute-backed mandates (no metrics, timelines, or reporting requirements are included).
Implementation questions remain unresolved. The resolution highlights a high burden of shunt failures, pediatric admissions, and underdiagnosed normal pressure hydrocephalus, yet it does not propose how to expand surgical capacity, improve device reliability, or resolve the pediatric-to-adult transition bottleneck.
Similarly, the connection to servicemember TBIs is flagged without asking the VA, DoD, or HHS to establish screening protocols, surveillance, or targeted research funding—leaving it to future legislation or agency initiative to translate visibility into programs.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.